Sign in

CIK 0001501697 · Non-accelerated filer<br>Smaller reporting company

X4 Pharmaceuticals, Inc

Sign in to watch
Ticker
XFOR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
273181608
Phone
857-529-8300
Business address
61 NORTH BEACON STREET, 4TH FLOOR, BOSTON, MA, 02134
Former names
Arsanis, Inc.
  1. 4 Open-market sale Chief Operating Officer sold 22,258 shares at $0.45 ($10,094)
  2. 4 Open-market sale Chief Medical Officer sold 11,624 shares at $0.45 ($5,284)
  3. 4 Open-market sale President and CEO sold 31,897 shares at $0.39 ($12,583)
  4. 4 Open-market sale President and CEO sold 31,897 shares at $0.56 ($17,926)
  5. 4 Open-market sale Chief Financial Officer sold 230,645 shares at $0.55 ($126,901)
  6. 4 Open-market sale Chief Commercial Officer sold 11,127 shares at $0.58 ($6,506)
  7. 4 Open-market sale President and CEO sold 239,436 shares at $0.55 ($131,522)
  8. 4 Open-market sale Chief Operating Officer sold 67,695 shares at $0.57 ($38,329)
  9. 4 Open-market sale Chief Scientific Officer sold 76,920 shares at $0.56 ($43,306)
  10. 4 Open-market sale Chief Operating Officer sold 2,642 shares at $0.66 ($1,738)
  11. 4 Grant or award Director acquired 45,000 shares (grant or award)
  12. 4 Grant or award Director acquired 45,000 shares (grant or award)
  13. 4 Grant or award Director acquired 45,000 shares (grant or award)
  14. 4 Grant or award Director acquired 45,000 shares (grant or award)
  15. 4 Grant or award Director acquired 45,000 shares (grant or award)
  16. 4 Grant or award Director acquired 45,000 shares (grant or award)
  17. 4 Grant or award Director acquired 45,000 shares (grant or award)
  18. 4 Grant or award Director acquired 45,000 shares (grant or award)
  19. 4 Open-market sale Chief Scientific Officer sold 14,235 shares at $0.88 ($12,552)
  20. 4 Open-market sale President and CEO sold 49,678 shares at $0.88 ($43,856)

Page 3 of 17 · 329 filings